Abingdon, United Kingdom

Peter David Johnson

This inventor holds 31 USPTO granted patents and 10 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Huntingtin Protein Imaging. Top assignees: Chdi Foundation, Inc., Summit Corporation Plc, Summit Therapeutics Plc. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter David Johnson. Retrieved from https://idiyas.com/inventor/peter-david-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 83.9

 

 

Average Co-Inventor Count = 8.3

ph-index = 6

Forward Citations = 153(Granted Patents)


Location History:

  • Oxford, GB (2011 - 2013)
  • Abingdon Oxfordshire, GB (2015)
  • Abingdon, GB (2016 - 2021)
  • Southampton, GB (2020 - 2023)
  • Oxfordshire, GB (2015 - 2024)
  • Wantage, GB (2024)

Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Huntingtin Protein
Imaging Agents
Kynurenine Inhibitors
Antibacterial Compounds
Fc Gamma RIIb
CD20 Antibodies
Pharmaceutical Compositions
Duchenne Muscular Dystrophy
31 patents (USPTO):Explore Patents

Title: **Peter David Johnson: An Innovator in Protein Imaging**

Introduction

Peter David Johnson, a prominent inventor based in Abingdon, GB, has made significant contributions to the field of protein imaging, securing a remarkable portfolio of 25 patents throughout his career. His innovative work focuses primarily on compounds and imaging agents that facilitate the detection of conditions associated with protein aggregation, particularly in relation to the huntingtin protein.

Latest Patents

Among his latest patents, Johnson has developed two noteworthy innovations:

1. **Compounds and Probes for Imaging Huntingtin Protein**: This patent provides a comprehensive description of certain compounds and imaging agents that are instrumental in detecting conditions or disorders linked to protein aggregation, along with methods for their use.

2. **Heterocyclic Compounds and Imaging Agents for Imaging Huntingtin Protein**: Similar to his previous work, this patent outlines compounds and imaging agents beneficial for identifying diseases associated with protein aggregation, detailing compositions and methods for their applications.

Career Highlights

Johnson's impressive career includes notable tenures at respected organizations such as the CHDI Foundation, Inc. and Summit Corporation Plc. His work in these companies has allowed him to embark on groundbreaking research and development initiatives in the field of protein imaging.

Collaborations

Throughout his journey, Johnson has collaborated with esteemed colleagues, including Celia Dominguez and Michael Edward Prime. These partnerships have played a vital role in enhancing his research capabilities and expanding the scope of his innovations.

Conclusion

Peter David Johnson represents a significant figure in the realm of innovations related to protein imaging. His contributions through various patents and collaborations reflect his dedication to advancing scientific understanding and technology in detecting protein aggregation disorders. As he continues to develop new ideas and solutions, his impact on the field is sure to be profound.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…